Susceptibility mutation for breast and ovarian cancer
US5756294A · kind A · utility
13Cited by
7References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 25, 1995 |
| Grant date | May 26, 1998 |
| Priority date | — |
| Expiry date | Sep 25, 2015 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/156
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
A new mutation has been found in the BRCA1 gene. The mutation is a two base pair deletion at nucleotides 3888 and 3889 of the published cDNA sequence of BRCA1 (GENBANK ACCESSION NO:U14680). The invention provides a method for diagnosing persons at risk of developing breast or ovarian cancer. The invention also provides a further tool with which to characterize tumors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.